RICT 2018
Conferences > Archives > RICT 2018
Wednesday July 4, 2018
07:30Registration
09:00Opening and Inaugural Lecture
Session Chair
Dr Luc VAN HIJFTE
(SCT & MERCACHEM-SYNCOM, Nijmegen, The Netherlands)
09:30PL01 - Disrupting Cancer Care & Outcomes by Putting Patients in the Driving Seat
Dr Anne BRUINVELS
(PX HEALTHCARE, London, United Kingdom)
Session 1 - New Breakthrough in GPCR Structure, Function and Drug Discovery
Session Chair
Dr Luc VAN HIJFTE
(SCT & MERCACHEM-SYNCOM, Nijmegen, The Netherlands)
10:15PL02 - Chemogenetic Approachs to Validate Poorly Characterised GPCRS
Prof. Graeme MILLIGAN
(UNIVERSITY OF GLASGOW, Glasgow, United Kingdom)
11:00Coffee break and Exhibition
Session Chair
Prof. Dominique BONNET
(CNRS-UNIVERSITY OF STRASBOURG, Illkirch, France)
11:30PL03 - Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism
Dr Patrick SCHNIDER
(ROCHE PHARMACEUTICAL, Basel, Switzerland)
12:15PL04 - Ghrelin Receptor Ligands: from the Bench to the Drug on the Market
Dr Jean-Alain FEHRENTZ
(CNRS-UNIVERSITY OF MONTPELLIER, Montpellier, France)
13:00Lunch
13:30Poster session and Exhibition
Session sponsored by Sanofi
Session Chair
Dr Gilbert MARCINIAK
(SANOFI, Strasbourg, France)
15:00PL05 - Structure-Based Drug Discovery for G Protein-Coupled Purine Receptors
Prof. Kenneth A. JACOBSON
(NIDDK, Bethesda, United States)
15:45PL06 - Structure-guided Development of Selective GPCR Ligands
Prof. Peter GMEINER
(FRIEDRICH ALEXANDER UNIVERSITY, Erlangen, Germany)
16:30Coffee break and Exhibition
Session 2 - Novel Synthetic Methods For Therapeutic Innovation (sponsored by the LabEx MEDALIS)
Session Chair
Dr Alain WAGNER
(CNRS/UNIVERSITY OF STRASBOURG, Illkirch, France)
17:00PL07 - Late Stage Fluorination for Medicine
Prof. Véronique GOUVERNEUR
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)
17:45PL08 - Single Electron Processes Enabling Organic Synthesis
Prof. Gary A. MOLANDER
(UNIVERSITY OF PENNSYLVANIA, Philadelphia, United States)
18:30Welcome and networking reception
Thursday July 5, 2018
Session sponsored by Janssen Research & Development
Session Chair
Prof. Sebastien PAPOT (SCT & UNIVERSITY OF POITIERS, Poitiers, France)
Ms Sandrine GROSSE (JANSSEN, Beerse, Belgium)
08:30PL09 - Paul Ehrlich Award Lecture - Chemical Biology on the Genome
Prof. Sir Shankar BALASUBRAMANIAN
(UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom)
Session 3 - Biologically Active Chemical SpaceSession 4 - Chemokine Targeted Drug Discovery
Session Chair
Prof. Sebastien PAPOT
(SCT & UNIVERSITY OF POITIERS, Poitiers, France)
Session Chair
Dr Sébastien ALBRECHT
(UNIVERSITY OF HAUTE-ALSACE, Mulhouse, France)
09:30PL10 - Ancient and Modern Scaffolds for Biologically Active Chemical Space
Prof. Arasu GANESAN
(UNIVERSITY OF EAST ANGLIA, Norwich, United Kingdom)
PL11 - Identification of Chemokine Neutraligands Targeting Atopic Diseases and Hyperalgesia
Dr Jean-Luc GALZI
(CNRS-UNIVERSITY OF STRASBOURG, Illkirch, France)
10:15Coffee break and Exhibition
Session 5 - Advances in GPCR drug discoverySession 6 - Advances in Biological Imaging
Session Chair
Prof. Marcel HIBERT
(UNIVERSITÉ DE STRASBOURG, ILLKIRCH, France)
Session Chair
Prof. Maria DUCA
(UNIVERSITÉ CÔTE D'AZUR, Nice, France)
11:00KL01 - Discovery of The Clinical Candidate Ribuvaptan, a Dual Acting Vasopressin V1a/V2 Receptor Antagonist for the Treatment of Heart Failure
Dr Carsten SCHMECK
(BAYER, Wuppertal, Germany)
KL03 - Dye-loaded Lipid Nanoparticles: Contrast Agents for Image-guided Surgery and Tools for Drug Delivery
Dr Isabelle TEXIER
(LETI-HEALTH, Grenoble, France)
11:30KL02 - Discovery of New Brain Penetrating Neuropeptide S Receptor (NPSR) Antagonists
Dr Julien POTHIER
(IDORSIA PHARMACEUTICALS LTD., Allschwil, Switzerland)
KL04 - Inducible Chemical-genetic Fluorescent Markers for Bioimaging
Dr Arnaud GAUTIER
(ECOLE NORMALE SUPÉRIEURE, Paris, France)
12:00Lunch
12:30Poster session and Exhibition
13:00Career Session
Session 7 - Challenging Targets and Approaches (sponsored by Institut de Recherche Servier)Session 8 - Understanding Binding Characteristics
Session Chair
Dr Arnaud LE TIRAN
(INSTITUT DE RECHERCHES SERVIER, Croissy sur Seine, France)
Session Chair
Prof. Didier ROGNAN
(CNRS-UNIVERSITY OF STRASBOURG, Illkirch, France)
14:00PL12 - Discovery of Foliglurax, an mGluR4 PAM for the Treatment of Parkinson’s Disease
Dr Stephan SCHANN
(DOMAIN THERAPEUTICS SA, Illkirch, France)
PL14 - Pharmacophore-based Analysis of Molecular Dynamics Trajectories: Towards Understanding KD of Protein Ligands
Prof. Thierry LANGER
(UNIVERSITY OF VIENNA, Vienna, Austria)
14:45PL13 - Potential Therapeutic Targets in the Brain Renin-Agiotensin and Apelinergic Systems for Treatment of Cardiovascular Diseases
Dr Catherine LLORENS-CORTES
(INSERM/COLLÈGE DE FRANCE, Paris, France)
PL15 - Identifying Inter-Helical Interactions Involved in GPCR Structure-Function and the Forces that Determine Receptor-Ligand Residence Time
Dr Alexander HEIFETZ
(EVOTEC, Abingdon, United Kingdom)
15:30KL05 - Topical Intestinal Agonists of the Bile Acid Receptor TGR5: Controlling Target Engagement by Innovative Molecular Engineering
Dr Julie CHARTON
(UNIVERSITY OF LILLE, INSTITUT PASTEUR DE LILLE, Lille, France)
KL06 - Drug-target Residence Time – a Misleading Concept
Dr Rutger FOLMER
(MERCACHEM, Nijmegen, The Netherlands)
16:00Coffee break and Exhibition
Session 9 - Tackling Challenges in Drug DeliverySession 10 - Chemistry Driven Biological Exploration
Session Chair
Prof. Line BOUREL
(FACULTÉ DE PHARMACIE, ILLKIRCH, France)
Session Chair
Prof. Stefan LAUFER
(UNIVERSITY OF TÜBINGEN, Tübingen, Germany)
16:30PL16 - Cellular Delivery and Oral Uptake of Cyclic Peptides
Dr Thomas VORHERR
(NOVARTIS, Basel, Switzerland)
PL18 - Chemistry as the Helping Tool to Develop New Therapeutic Strategies
Prof. Maria Luz LOPEZ RODRIGUEZ
(COMPLUTENSE UNIVERSITY OF MADRID, Madrid, Spain)
17:15PL17 - Nanoparticle-based Strategies in Oncology
Prof. Jean-Pierre BENOIT
(UNIVERSITY OF ANGERS, Angers, France)
PL19 - Chemical Tools to Probe Reversible Lysine Acetylation
Prof. Manfred JUNG
(ALBERT LUDWIGS UNIVERSITY OF FREIBURG, Freiburg, Germany)
20:00Banquet
Friday July 6, 2018
Session 11 - New modalities in Drug Discovery (sponsored by Institut de Recherche Pierre Fabre)
Session Chair
Dr Pascal GEORGE (SCT & INDEPENDENT SCIENTIFIC EXPERT & ADVISER, Longvilliers, France)
Mr Philippe SCHAMBEL (INSTITUT DE RECHERCHE PIERRE FABRE, TOULOUSE, France)
08:30PL20 - The Confobody Technology, a New Platform to Enable Fragment Screening on GPCRs
Dr Christel MENET
(CONFO THERAPEUTICS, Brussels, Belgium)
09:15PL21 - Pierre Fabre Award lecture
PROTAC-mediated Protein Degradation: A New Therapeutic Modality
Prof. Craig CREWS
(UNIVERSITY OF YALE, New Haven, United States)
10:00Coffee break and Exhibition
Session 12 - Chemistry in Living Systems
Session Chair
Prof. Rebecca DEPREZ-POULAIN
(UNIVERSITY OF LILLE, Lille, France)
10:30PL22 - Two Adventures in Chemical Biology - in vivo Chemistry and Real-time Optical Medical Imaging
Prof. Mark BRADLEY
(UNIVERSITY OF EDINBURGH, Edinburgh, United Kingdom)
11:15PL23 - Therapeutic In Vivo Synthetic Chemistry
Prof. Nori TANAKA
(RIKEN, Saitama, Japan)
12:00Concluding remarks
Prof. Pascal MARCHAND (UNIVERSITY OF NANTES, Nantes, France)
Prof. Sebastien PAPOT (SCT & UNIVERSITY OF POITIERS, Poitiers, France)

Copyright 2018 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys